PRESS RELEASE
18 February 2020

The Outlook On CBD: What Does 2020 Have In Store For The CBD Market? - BenefitsPro

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
Will Garvin, shareholder in the firm's Life Sciences industry, authored "The Outlook on CBD: What Does 2020 Have in Store for the CBD Market?," published in BenefitsPro.
United States

Will Garvin, shareholder in the firm's Life Sciences industry, authored "The Outlook on CBD: What Does 2020 Have in Store for the CBD Market?," published in BenefitsPro

With a market estimated to grow more than 260% to a dizzying $1.25 billion over the next four years, it appears that the demand for cannabidiol, more commonly known as CBD, is expected to continue to grow. All of this growth is still expected despite the actions by the Food and Drug Administration (FDA).

Read the full article. (subscription required)

PRESS RELEASE
18 February 2020

The Outlook On CBD: What Does 2020 Have In Store For The CBD Market? - BenefitsPro

United States

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More